Enlivex Ltd.
ENLV- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001596812
No open-market purchases or sales by Enlivex Ltd. insiders were filed in the last 90 days; 25 institutions reported holding it in 13F filings for Q2 2026, worth $2.34M in total; ARK Invest is the only superinvestor holding it.
13F holders, Q1 2023
Institutional positions in Enlivex Ltd. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 19
- −1 vs. Q4 2022
- Shares held
- 343.3K
- +5.39K (+1.6%) vs. Q4 2022
- Total value
- $1.24M
- −$77.9K (−5.9%) vs. Q4 2022
- New holders
- 0
- 4 more added
- Sold out
- 1
- 7 more reduced
1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ENLV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 25 | $2.34M |
| Q1 2026 | 35 | $3.38M |
| Q4 2025 | 25 | $929.4K |
| Q3 2025 | 29 | $950.2K |
| Q2 2025 | 21 | $2.87M |
| Q1 2025 | 26 | $3.08M |
| Q4 2024 | 24 | $3.99M |
| Q3 2024 | 19 | $4.31M |
| Q2 2024 | 17 | $2.96M |
| Q1 2024 | 15 | $1.24M |
| Q4 2023 | 17 | $509.2K |
| Q3 2023 | 16 | $408.4K |
| Q2 2023 | 19 | $795.1K |
| Q1 2023 | 19 | $1.24M |
| Q4 2022 | 21 | $1.32M |
| Q3 2022 | 18 | $1.41M |
| Q2 2022 | 22 | $2.89M |
| Q1 2022 | 25 | $4.75M |
| Q4 2021 | 23 | $4.12M |
| Q3 2021 | 20 | $8.38M |
| Q2 2021 | 20 | $8.79M |
| Q1 2021 | 23 | $11.7M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Enlivex Ltd.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 72 | $0 | 0.00% | −26−26.5% | Reduced |
| Advisory Services Network, LLC | 43 | $157 | 0.00% | 00.0% | Unchanged |
| Red Tortoise LLC | 150 | $546 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 400 | $1.46K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 838 | $3.05K | 0.00% | +191+29.5% | Added |
| Barclays PLC | 1,000 | $3.64K | 0.00% | 00.0% | Unchanged |
| Steward Partners Investment Advisory, LLC | 3,000 | $10.9K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 10,420 | $37.9K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 10,696 | $38.9K | 0.00% | −1,050−8.9% | Reduced |
| Simplex Trading, LLC | 12,713 | $46.0K | 0.00% | +4,560+55.9% | Added |
| Edmond de Rothschild Holding S.A. | 13,000 | $47.3K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 13,499 | $49.1K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group Ltd. | 17,866 | $65.0K | 0.04% | −1,021−5.4% | Reduced |
| Goldman Sachs Group Inc | 18,870 | $68.7K | 0.00% | −38−0.2% | Reduced |
| UBS Group AG | 31,453 | $114.5K | 0.00% | −1,992−6.0% | Reduced |
| Morgan Stanley | 40,159 | $146.2K | 0.00% | −567−1.4% | Reduced |
| Citadel Advisors LLC | 49,464 | $180.0K | 0.00% | −10,068−16.9% | Reduced |
| Renaissance Technologies LLC | 54,689 | $199.0K | 0.00% | +500+0.9% | Added |
| Compagnie Lombard Odier SCmA | 65,000 | $225.5K | 0.01% | +15,000+30.0% | Added |
| EWG Elevate Inc. | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Sargent Bickham Lagudis LLC | – | – | – | – | Not filed |